Compare MESO & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | USAS |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | Australia | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2005 | 2004 |
| Metric | MESO | USAS |
|---|---|---|
| Price | $13.68 | $2.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $37.00 | $7.54 |
| AVG Volume (30 Days) | 255.3K | ★ 3.9M |
| Earning Date | 08-26-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.63 | $102.27 |
| Revenue Next Year | $63.39 | $70.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.89 | $2.67 |
| 52 Week High | $21.50 | $10.50 |
| Indicator | MESO | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 38.08 |
| Support Level | $11.89 | $2.67 |
| Resistance Level | $16.03 | $5.25 |
| Average True Range (ATR) | 0.50 | 0.20 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 40.72 | 43.92 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.